Particle.news
Download on the App Store

Lancet Study Links White House Autism Briefing to Rapid Shifts in Tylenol and Leucovorin Use

Researchers document abrupt prescribing swings following the Sept. 22 briefing, highlighting political messaging’s sway over care despite scant supporting evidence.

Overview

  • Analyzing electronic records from more than 1,600 hospitals and 37,000 clinics, researchers found ED acetaminophen orders for pregnant patients fell about 10% after Sept. 22, with a 20% weekly low in week three.
  • Outpatient leucovorin prescriptions for children ages 5–17 rose roughly 71% overall, spiking 93% in the first month and more than doubling in week two.
  • Orders for pregnant patients trended back toward baseline by early December, whereas leucovorin prescribing remained elevated through the study period.
  • Authors emphasize the study shows associations, not causation, and note limits including no over‑the‑counter tracking, unclear patient versus clinician drivers, and no assessment of outcomes.
  • Major medical groups and the FDA rejected the White House claims as unsupported, an HHS spokesperson defended the messaging, and clinicians warned of untreated fevers in pregnancy and a reported leucovorin shortage affecting chemotherapy care.